Simmons Cancer Institute at SIU Banner
Link: Patient Care
Link: Clinical Trials
Link: Cancer Information
Link: About Us
Link: How to Help
Quick Links below
Link: New Patients
Link: Patient Navigator
Link: Side by Side Program
Link: Support Groups
Link: Maps and Locations
Link: Cancer Wellness
Link: Outreach Program
Physycians and Health Care Professionals links below
Link: Web-based CME Programs
Link: Membership
Link: Research
Link: Grant and Funding
Link: SCCI Home Page
Link: Prevention Tips and Screenings
Link: News


Cancer Prevention, Control and Symptom Management Studies Currently Recruiting Participants at the Simmons Cancer Research Center at Southern Illinois University School of Medicine

Protocol Title Study # Study Group
Anthracycline Based Chemo
A Multi-Center Study in Patients Undergoing Anthracycline-Based Chemotherapy to Assess the Effectiveness of Using Biomarkers to Detect and Identify Cardiotoxicity and Describe Treatment MDA 2007-0914 CICCOP
Behavioral and Psychosocial Oncology
Retrospective and Prospective Study to Assess the Effects of Distress Screening & Reminder Checklist on Patient Satisfaction with Cancer 08-141 SIU Behavioral & Psychosocial Oncology
Residual Neuropsychological Deficits in Adults Post-Chemotherapeutic Treatment 09-139 SIU Behavioral & Psychosocial Oncology
Alterations in Neuropsychological Functioning in Adults Receiving Chemotherapy for Systemic and/or Adjuvant Disease Treatment 09-140 SIU Behavioral & Psychosocial Oncology
Bone Pain
A Randomized, Phase III Study of Standard Dosing Versus Longer Dosing Interval of Zoledronic Acid in Metastatic Cancer CTSU CALGB 70604 CICCOP
Breast
Assessment of Cognitive Function in Breast Cancer and Lymphoma Patients Receiving Chemotherapy at Pre-Treatment,Post-Treatment and at Six Months Follow Up URCC U10054 CICCOP
A Study to Evaluate Different Decision-Making Approaches Used by Women Known to be at Increased Risk for Breast Cancer NSABP DMP-1 CICCOP
Phase II Placebo-controlled Trial of Lisinopril and Coreg CR® to Reduce Cardiotoxicity in Patients With Breast Cancer Receiving (Neo)Adjuvant Chemotherapy With Trastuzumab (Herceptin®) CTSU SCUSF-0806 CICCOP
Breast & Lymphoma    
Assessment of Cognitive Function in Breast Cancer and Lymphoma Patients Receiving Chemotherapy at Pre-Treatment,Post-Treatment and at Six Months Follow Up URCC U10055 CICCOP
Colorectal    
Comparative Study of Oncologist Recommended, Home-Based Exercise Program and Relaxation Training for Physical Functioning and Symptom Control in Colon Cancer Patients MDA 2009-0288 CICCOP
A Phase III Randomized, Placebo-Controlled, Double-Blind Study of Intravenous Calcium/Magnesium in Two Different Versions to Prevent Oxaliplatin-Induced Sensory Neurotoxicity CTSU-NCCTG N08CB CICCOP
Statin Polyp Prevention Trial in Patients With Resected Colon Cancer NSABP P-5 SIU Behavioral & Psychosocial Oncology
Exercise    
A Study of the Effects of Exercise on Cancer-Related Fatigue URCC 08106 CICCOP
Lung    
Compare the Outcomes of Four Groups of Lung cancer Patients Who Consent to Participate Behavior Outcomes Trial SIU Thoracic
Nausea
Randomized, Double-Blind, Placebo-Controlled Trial of Palonosetron/Dexamethasone With or Without Dronabinol for the Prevention of Chemotherapy-Induced Nausea and Vomiting After Moderately Emetogenic Chemotherapy MDA 2006-0841 CICCOP
Neuropathy Prevention    
The Use of Glutathione (GSH) for Prevention of Paclitaxel/Carboplatin (TAXOL/CBDCA) Induced Peripheral Neuropathy: A Phase III Randomized, Double-Blind Placebo Controlled Study CTSU-CALGB N08CA CICCOP
Osteonecrosis of the Jaw
A Prospective Observational Multicenter Cohort Study to Assess the Incidence of Osteonecrosis of the Jaw (ONJ) in Cancer Patients With Bone Metastases Starting Zoledronic Acid Treatment SWOG S0702 CICCOP
Prostate
A Randomized Phase II Dose Finding Study of ArginMax for Its Effect on Erectile Function and Quality of Life in Survivors of Prostate Cancer Previously Treated With Radiotherapy CCCWFU 9811 CICCOP
Gynecologic
Nurse-Delivered Write Symptoms vs Self-Directed Write Symptoms vs Care as Usual for Optimal Symptom Management for Women with Recurrent Ovarian, Fallopian Tube or Primary Peritoneal Cancer COG 259 CICCOP

Although our objective is to provide an updated listing of available clinical trials please note that a listing here does not guarantee that a trial is open or available to any specific patient and that there may be additional trials available that are not listed. Complete information is only available from a treating physician.


Contact Information:

Simmons Cancer Institute Clinical Trials Office
Mail Code 9677          Fax (217) 545-6823

Kathy Robinson, PhD,
Director of Clinical Trials
(217) 545-1946
 

Allicent Curry, RN,BSN, OCN
Research Nurse
(217) 545-7929
 
 
 
 
 

SIU Behavioral & Psychosocial Oncology

Anna Wiggins, MS, LCPC
(217) 545-5408
 

SIU COG

Carol Peterson, RN, CCRP (217) 545-7377

SIU IM

Amanda Fogleman, B.S. (217) 545-0592
Krista Whitlock (217) 545-7750

SIU Thoracic

Theresa Boley, RN, MSN, APN/FNP-BC, CCRP (217) 545-5000
 
Cathy Leslie, RN, CCRP, CCRP (217) 545-8184
Mary Ray, MS (217) 545-7420
 

RTOG:  Radiation Therapy Oncology Group:

Diana Weyhenmeyer, RN, MA, OCN  (217) 544-6464 ext. 45591

CICCOP:  Central Illinois Community Clinical Oncology Program
Memorial Medical Center CICCOP Research Contacts:

Treatment/Cancer Control:

Holly Thomas (217) 788-4178
Stephanie Allbritton (217) 788-3544
Brooke Trickey (217) 217-788-3560
Karen Graber (217) 588-2961
Chrissy Tucker (217) 788-4444
Sunny Hampsey (217) 788-4233

Back to Open Clinical Trials

Home / Patient Care / Clinical Trials / Cancer Information / How to Help / About Us
SIU-SM Home / About SIU-SM / Directories / News/Info / SIU Carbondale / Search / Privacy Policy
Copyright © 2010 Board of Trustees, Southern Illinois University
Contact the webmaster........ Last Updated 04/16/10........